Hearing:
"The Opioid Epidemic: Implications for the Federal Employees’ Compensation Act”
Subcommittee on Workforce Protections (Committee on Education and the Workforce)
Tuesday, May 8, 2018 (10:00 AM)
2175 RHOB
Washington, D.C.
Witnesses
Dr. Scott D. Szymendera
Acting Section Research Manager, Congressional Research Service, Library of Congress, Washington, D.C.
Added
05/04/2018 at 10:21 PM
- Testimony Szymendera
[PDF]
Added
05/08/2018 at 11:40 AM
Ms. Ramona P. Tanabe
Executive Vice President and Counsel, Workers Compensation Research Institute, Cambridge, MA
Added
05/04/2018 at 10:21 PM
- Testimony Tanabe
[PDF]
Added
05/08/2018 at 11:40 AM
- Witness Truth in Testimony
[PDF]
Added
05/08/2018 at 11:40 AM
Mrs. Joe Paduda
President, CompPharma, LLC, Maggie Valley, NC
Added
05/04/2018 at 10:21 PM
- Testimony Paduda
[PDF]
Added
05/08/2018 at 11:40 AM
- Witness Truth in Testimony
[PDF]
Added
05/08/2018 at 11:40 AM
The Honorable Scott S. Dahl
Office of the Inspector General, U.S. Department of Labor, Washington, D.C.
Added
05/04/2018 at 10:21 PM
- Testimony Dahl
[PDF]
Added
05/08/2018 at 11:40 AM
First Published:
May 1, 2018 at 10:04 AM
Last Updated:
May 8, 2018 at 11:40 AM